Stocks are higher as report shows surprisingly strong retail sales in September.
As earnings season gets under way, watch these heavy hitters in the medical devices industry.
General Motors is upgraded to 'buy,' and Alcoa is downgraded to 'hold .'
The US approval of Stribild is a big plus for the company's AIDS treatment franchise.
Shares of a 3% dividend yield, solid blue-chip drug company are valuable in shaky economic times.
Vivus becomes the second pharma this year approved to sell a weight-loss treatment.
The banking giant reports a profit, and the semiconductor company reports earnings above expectations.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Jeff Bezos knows how to get the media excited about his company. But is that enough?
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Preteens, rejoice. The grown-ups have a compelling reason to consider getting you a tablet this year. Adults, listen up.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.